Yasons Chemex Care Limited (NSE:YCCL)
India · Delayed Price · Currency is INR 10.20
0.00 (0.00%)
Jun 10, 2026, 11:10 AM IST
Yasons Chemex Care Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Revenue | 968.19 | 765.33 | 692.43 | 367.73 | 250.52 |
Other Revenue | - | 0.29 | 2.89 | 20.18 | 0.12 |
| 968.19 | 765.62 | 695.33 | 387.9 | 250.64 | |
Revenue Growth (YoY) | 26.46% | 10.11% | 79.25% | 54.77% | 41.00% |
Cost of Revenue | 944.26 | 736.68 | 649.45 | 355.19 | 225.71 |
Gross Profit | 23.93 | 28.94 | 45.88 | 32.71 | 24.93 |
Selling, General & Admin | 10.15 | 7.59 | 8.16 | 1.47 | 1.65 |
Other Operating Expenses | -17.96 | -18.5 | 2.24 | -1.08 | 3.11 |
Operating Expenses | -4.16 | -7.13 | 14.69 | 1.4 | 6.05 |
Operating Income | 28.09 | 36.07 | 31.19 | 31.32 | 18.88 |
Interest Expense | -12.78 | -12.65 | -9.97 | -3.58 | -3.07 |
Interest & Investment Income | - | 0.59 | 0.12 | 0.58 | 1.97 |
Earnings From Equity Investments | - | - | - | 14.35 | 8.04 |
Currency Exchange Gain (Loss) | - | - | 0.03 | - | -0.22 |
Other Non Operating Income (Expenses) | - | -1.7 | -3.33 | -0.53 | -0.49 |
Pretax Income | 15.31 | 22.31 | 18.04 | 42.14 | 25.11 |
Income Tax Expense | 5.93 | 6.1 | 5.57 | 7.86 | 5.57 |
Earnings From Continuing Operations | 9.38 | 16.21 | 12.48 | 34.28 | 19.54 |
Minority Interest in Earnings | -0.01 | -0.09 | -0.07 | - | - |
Net Income | 9.38 | 16.12 | 12.41 | 34.28 | 19.54 |
Net Income to Common | 9.38 | 16.12 | 12.41 | 34.28 | 19.54 |
Net Income Growth | -41.81% | 29.88% | -63.80% | 75.41% | 55.89% |
Shares Outstanding (Basic) | 19 | 19 | 18 | 14 | 14 |
Shares Outstanding (Diluted) | 19 | 19 | 18 | 14 | 14 |
Shares Change (YoY) | -0.85% | 9.69% | 24.27% | - | - |
EPS (Basic) | 0.49 | 0.83 | 0.71 | 2.42 | 1.38 |
EPS (Diluted) | 0.49 | 0.83 | 0.71 | 2.42 | 1.38 |
EPS Growth | -40.96% | 17.72% | -70.86% | 75.38% | 55.89% |
Free Cash Flow | -9.8 | -25.11 | -162.39 | -2.7 | -0.1 |
Free Cash Flow Per Share | -0.51 | -1.30 | -9.23 | -0.19 | -0.01 |
Gross Margin | 2.47% | 3.78% | 6.60% | 8.43% | 9.95% |
Operating Margin | 2.90% | 4.71% | 4.49% | 8.07% | 7.53% |
Profit Margin | 0.97% | 2.10% | 1.79% | 8.84% | 7.80% |
Free Cash Flow Margin | -1.01% | -3.28% | -23.36% | -0.70% | -0.04% |
EBITDA | 31.74 | 39.85 | 35.48 | 32.33 | 20.18 |
EBITDA Margin | 3.28% | 5.21% | 5.10% | 8.33% | 8.05% |
D&A For EBITDA | 3.65 | 3.78 | 4.29 | 1.01 | 1.29 |
EBIT | 28.09 | 36.07 | 31.19 | 31.32 | 18.88 |
EBIT Margin | 2.90% | 4.71% | 4.49% | 8.07% | 7.53% |
Effective Tax Rate | 38.72% | 27.34% | 30.85% | 18.66% | 22.18% |
Revenue as Reported | 1,006 | 793.16 | 701.99 | 410.06 | 261.7 |